MARKET WIRE NEWS
  1. Home
  2. Stock
  3. NGENF
  4. News
NGENF
Quote
Short
News
Articles
Message Board

NervGen Pharma Corp (OTCMKTS : NGENF ) News

NervGen Pharma Corp (OTCMKTS: NGENF) News Releases

NGENF News Releases
NGENF : OTC
GlobeNewswire
NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange
NGENF : OTC
GlobeNewswire
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs
NGENF : OTC
GlobeNewswire
NervGen Pharma to Participate at Upcoming Investor Conferences
NGENF : OTC
GlobeNewswire
NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams
NGENF : OTC
GlobeNewswire
NervGen Pharma to Present at Unite2Fight Paralysis' 20th Annual Science and Advocacy Symposium
NGENF : OTC
GlobeNewswire
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company's Growth and Execution of Its Mission in Spinal Cord Injury
NGENF : OTC
GlobeNewswire
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
NGENF : OTC
GlobeNewswire
NervGen Pharma Begins Trading on Nasdaq Today
NGENF : OTC
Newsfile
NervGen Pharma Announces Filing of Form F-10 Registration Statement with The SEC Under MJDS
NGENF : OTC
Newsfile
NervGen Pharma Announces Proposed Amendment to Warrants

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.